Metraipolis › archive › dc_8512e76e2666

The Importance of Continuous Monitoring in Identifying Bradycardia during Propranolol Treatment for Infantile Hemangiomas — Europe PMC PMID:41676847

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41676847
DOI
10.31662/jmaj.2025-0213
License (as archived)
solo-consultazione
Archived
2026-11-08T04:35:45.552Z
SHA-256 of the archived text
756deaa9884a96f2246a8557321d9ad9355239956a4b28cbf30c3bad9808e476
Stable URL of this page
https://metraipolis.com/documento/dc_8512e76e2666

How to cite

The Importance of Continuous Monitoring in Identifying Bradycardia during Propranolol Treatment for Infantile Hemangiomas — Europe PMC PMID:41676847 — Europe PMC (en), https://europepmc.org/article/MED/41676847 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8512e76e2666 (Metraipolis archive dc_8512e76e2666, sha256 756deaa9884a96f2246a8557321d9ad9355239956a4b28cbf30c3bad9808e476)
BibTeX
@misc{dc8512e76e2666,
  title = {The Importance of Continuous Monitoring in Identifying Bradycardia during Propranolol Treatment for Infantile Hemangiomas — Europe PMC PMID:41676847},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41676847},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8512e76e2666; sha256 756deaa9884a96f2246a8557321d9ad9355239956a4b28cbf30c3bad9808e476},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41676847. Agents can read the archived copy with the MCP tool read_document.